PT2261215E - Processo para preparar compostos de benzazepina ou seus sais - Google Patents

Processo para preparar compostos de benzazepina ou seus sais Download PDF

Info

Publication number
PT2261215E
PT2261215E PT101740009T PT10174000T PT2261215E PT 2261215 E PT2261215 E PT 2261215E PT 101740009 T PT101740009 T PT 101740009T PT 10174000 T PT10174000 T PT 10174000T PT 2261215 E PT2261215 E PT 2261215E
Authority
PT
Portugal
Prior art keywords
salts
preparing
compounds
benzazepine compounds
benzazepine
Prior art date
Application number
PT101740009T
Other languages
English (en)
Inventor
Yasuhiro Torisawa
Kaoru Abe
Yasuaki Muguruma
Shigekazu Fujita
Hidenori Ogawa
Naoto Utsumi
Masahiro Miyake
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37398782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2261215(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT2261215E publication Critical patent/PT2261215E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PT101740009T 2005-09-02 2006-09-01 Processo para preparar compostos de benzazepina ou seus sais PT2261215E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005254744 2005-09-02

Publications (1)

Publication Number Publication Date
PT2261215E true PT2261215E (pt) 2015-02-13

Family

ID=37398782

Family Applications (3)

Application Number Title Priority Date Filing Date
PT06797660T PT1919874E (pt) 2005-09-02 2006-09-01 Processo para preparar compostos de benzazepina ou sais dos mesmos
PT101740009T PT2261215E (pt) 2005-09-02 2006-09-01 Processo para preparar compostos de benzazepina ou seus sais
PT10174006T PT2251319E (pt) 2005-09-02 2006-09-01 Processo para preparar derivados de ácido benzóico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT06797660T PT1919874E (pt) 2005-09-02 2006-09-01 Processo para preparar compostos de benzazepina ou sais dos mesmos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT10174006T PT2251319E (pt) 2005-09-02 2006-09-01 Processo para preparar derivados de ácido benzóico

Country Status (16)

Country Link
US (2) US8273735B2 (pt)
EP (3) EP1919874B1 (pt)
JP (6) JP5046587B2 (pt)
KR (4) KR101019363B1 (pt)
CN (4) CN102746229B (pt)
AT (2) ATE544744T1 (pt)
CY (3) CY1111788T1 (pt)
DE (1) DE602006019882D1 (pt)
DK (3) DK1919874T3 (pt)
ES (3) ES2379153T3 (pt)
HK (5) HK1124318A1 (pt)
IL (5) IL189481A (pt)
PL (3) PL2251319T3 (pt)
PT (3) PT1919874E (pt)
SI (3) SI2251319T1 (pt)
WO (1) WO2007026971A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2379153T3 (es) * 2005-09-02 2012-04-23 Otsuka Pharmaceutical Co., Ltd. Proceso para preparar derivados del ácido benzoico
JP2009035513A (ja) * 2007-08-02 2009-02-19 Ube Ind Ltd ４−ｎ−（メチルベンゾイル）アミノ−２−メチル安息香酸の製法
CN102020609A (zh) * 2009-09-17 2011-04-20 北京本草天源药物研究院 托伐普坦晶体或无定形物及其制备方法
CN101817783B (zh) * 2010-05-12 2012-02-22 天津泰普药品科技发展有限公司 一种托伐普坦中间体的制备方法
WO2012046244A1 (en) 2010-10-05 2012-04-12 Hetero Research Foundation Process for preparing tolvaptan intermediates
CN102093247B (zh) * 2010-12-15 2014-03-12 天津药物研究院 一种2-甲基-4-n-(2-甲基苯甲酰)苯甲酸的制备方法
CN102060769B (zh) * 2010-12-20 2013-09-18 天津药物研究院 一种托伐普坦的制备方法
CN102093293B (zh) * 2011-03-02 2012-06-13 宁波人健药业集团有限公司 一种制备7-氯-2,3,4,5-四氢-1h-1-苯并氮杂卓-5-酮的方法
CN102558051B (zh) * 2011-07-15 2016-08-10 天津泰普药品科技发展有限公司 一种托伐普坦晶体及其药物组合物
CN102382053B (zh) * 2011-08-31 2016-06-01 浙江华海药业股份有限公司 一种制备托伐普坦中间体的方法
CN102329268B (zh) * 2011-10-25 2014-03-12 天津药物研究院 7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
CN102690211B (zh) * 2012-06-05 2015-12-09 郑州明泽医药科技有限公司 托伐普坦中间体的制备方法
CN103012265B (zh) * 2012-11-23 2014-10-15 天津药物研究院 一种7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN103012266B (zh) * 2012-11-23 2014-07-23 天津药物研究院 一种7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN104418803A (zh) * 2013-08-21 2015-03-18 上海天慈生物谷生物工程有限公司 一种托伐普坦的制备方法
IN2013MU03296A (pt) 2013-10-21 2015-07-17 Rpg Life Sciences Ltd
CN103880747B (zh) * 2014-03-20 2015-08-26 成都百裕科技制药有限公司 无定形托伐普坦的制备方法
CN106883175A (zh) * 2015-12-16 2017-06-23 天津泰普制药有限公司 一种托伐普坦的制备方法
ITUB20160256A1 (it) * 2016-01-15 2017-07-15 Olon Spa Derivati idrossibenzazepinici esterificati e loro impiego nella sintesi di tolvaptan
CN107663171A (zh) * 2017-10-10 2018-02-06 常州市阳光药业有限公司 高纯度托伐普坦的制备方法
CN113004202B (zh) * 2019-12-20 2023-10-24 成都倍特药业股份有限公司 一种高纯度托伐普坦的制备方法
CN113717070A (zh) * 2020-05-25 2021-11-30 南京正大天晴制药有限公司 一种升压素v2受体拮抗剂的中间体的制备方法
JP2024521354A (ja) 2021-06-02 2024-05-31 エスペリオン・セラピューティクス・インコーポレイテッド ベンペド酸とトルバブタンを含む組成物及びそれらを用いた治療方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965144A (en) * 1973-08-13 1976-06-22 Syva Company Carbanilate compound for erythemal protection
DE2412855C2 (de) * 1974-03-18 1983-03-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Carbonsäuren
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
CA1255327A (en) * 1984-07-24 1989-06-06 Celanese Corporation Process for producing acyloxy aromatic carboxylic acid
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DE122009000062I2 (de) * 1989-10-20 2011-01-13 Otsuka Pharma Co Ltd Benzoheterozyklische verbindungen
JP2927513B2 (ja) * 1990-07-05 1999-07-28 科学技術振興事業団 四級ピリジニウム化合物
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) * 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
JPH07154765A (ja) * 1993-11-29 1995-06-16 Hitachi Ltd 画像通信端末
JPH09168396A (ja) 1995-10-19 1997-06-30 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシ−２，３，４，５−テトラヒドロ−１ｈ−ベンゾアゼピン誘導体の製造方法
ZA9610853B (en) * 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
DE19617558A1 (de) * 1996-05-02 1997-11-06 Hoechst Ag Verfahren zur Herstellung von 4,5-Dichlor-2-methylbenzoesäure
US5710299A (en) * 1996-06-27 1998-01-20 Albemarle Corporation Production of bridged metallocene complexes and intermediates therefor
US6381531B1 (en) * 1996-12-02 2002-04-30 Robert Bosch Gmbh Process and device for adjusting the braking effect in a vehicle
JPH10182681A (ja) * 1996-12-27 1998-07-07 Nippon Petrochem Co Ltd ビスアルキルシクロペンタジエニル錯体化合物の製造法
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
GB0111566D0 (en) * 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide
ES2379153T3 (es) * 2005-09-02 2012-04-23 Otsuka Pharmaceutical Co., Ltd. Proceso para preparar derivados del ácido benzoico
JP2009035513A (ja) * 2007-08-02 2009-02-19 Ube Ind Ltd ４−ｎ−（メチルベンゾイル）アミノ−２−メチル安息香酸の製法

Also Published As

Publication number Publication date
JP2012197295A (ja) 2012-10-18
CN102219741A (zh) 2011-10-19
PL2261215T3 (pl) 2015-06-30
JP5784164B2 (ja) 2015-09-24
KR20110029184A (ko) 2011-03-22
CN101967107A (zh) 2011-02-09
EP2251319A2 (en) 2010-11-17
IL222396A (en) 2014-05-28
CY1112496T1 (el) 2015-12-09
DE602006019882D1 (de) 2011-03-10
WO2007026971A3 (en) 2007-07-05
CN102219741B (zh) 2013-05-15
IL189481A (en) 2013-08-29
DK2251319T3 (da) 2012-03-05
PT2251319E (pt) 2012-03-05
IL217446A0 (en) 2012-02-29
JP2012197296A (ja) 2012-10-18
WO2007026971A2 (en) 2007-03-08
JP2014139203A (ja) 2014-07-31
SI1919874T1 (sl) 2011-04-29
CN102746229A (zh) 2012-10-24
CY1116082T1 (el) 2017-02-08
KR101077329B1 (ko) 2011-10-26
CN101967107B (zh) 2012-12-12
JP2012176979A (ja) 2012-09-13
KR101019363B1 (ko) 2011-03-07
ATE496895T1 (de) 2011-02-15
HK1172329A1 (en) 2013-04-19
IL217445A (en) 2013-11-28
EP2261215B1 (en) 2014-12-31
EP1919874A2 (en) 2008-05-14
JP2014205699A (ja) 2014-10-30
KR20080039459A (ko) 2008-05-07
US8273735B2 (en) 2012-09-25
KR101119732B1 (ko) 2012-03-22
CY1111788T1 (el) 2015-10-07
KR20100132087A (ko) 2010-12-16
ES2379153T3 (es) 2012-04-23
EP2251319A3 (en) 2011-03-09
JP2007091738A (ja) 2007-04-12
ATE544744T1 (de) 2012-02-15
EP2251319B1 (en) 2012-02-08
JP5583172B2 (ja) 2014-09-03
JP5893083B2 (ja) 2016-03-23
DK2261215T3 (en) 2015-02-02
HK1148999A1 (en) 2011-09-23
IL217445A0 (en) 2012-02-29
PT1919874E (pt) 2011-03-14
CN101273017A (zh) 2008-09-24
US20090306369A1 (en) 2009-12-10
SI2261215T1 (sl) 2015-02-27
ES2527794T3 (es) 2015-01-29
JP5046587B2 (ja) 2012-10-10
US20120226034A1 (en) 2012-09-06
IL217446A (en) 2016-08-31
HK1124318A1 (en) 2009-07-10
HK1145835A1 (en) 2011-05-06
EP2261215A1 (en) 2010-12-15
SI2251319T1 (sl) 2012-05-31
CN102746229B (zh) 2015-04-08
IL217444A (en) 2013-05-30
PL1919874T3 (pl) 2011-06-30
CN101273017B (zh) 2011-09-14
IL189481A0 (en) 2008-08-07
IL217444A0 (en) 2012-02-29
ES2358217T3 (es) 2011-05-06
PL2251319T3 (pl) 2012-07-31
EP1919874B1 (en) 2011-01-26
US8501730B2 (en) 2013-08-06
KR20100133028A (ko) 2010-12-20
DK1919874T3 (da) 2011-02-21
HK1144932A1 (en) 2011-03-18

Similar Documents

Publication Publication Date Title
HK1172329A1 (en) Process for preparing benzazepine compounds or salts thereof
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
HUS1600009I1 (hu) Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények
IL176062A0 (en) Dpp-iv inhibitors
HK1157334A1 (en) Process for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3- benzazepine hydrochloride hemihydrate (r)-8--1--2345--1h-3-
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
HK1076816A1 (pt)
HK1064673A1 (en) Fused-polycyclic compounds
MY141657A (en) Novel intermediate for the preparation of therapeutically active imidazopyridines